These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30276970)

  • 1. Disaccharide-Based Anionic Amphiphiles as Potent Inhibitors of Lipopolysaccharide-Induced Inflammation.
    Borio A; Holgado A; Garate JA; Beyaert R; Heine H; Zamyatina A
    ChemMedChem; 2018 Nov; 13(21):2317-2331. PubMed ID: 30276970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics.
    Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A
    Front Immunol; 2021; 12():631797. PubMed ID: 33815382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
    Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
    Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ginsenoside Rh
    Pan S; Peng L; Yi Q; Qi W; Yang H; Wang H; Wang L
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformationally constrained lipid A mimetics for exploration of structural basis of TLR4/MD-2 activation by lipopolysaccharide.
    Artner D; Oblak A; Ittig S; Garate JA; Horvat S; Arrieumerlou C; Hofinger A; Oostenbrink C; Jerala R; Kosma P; Zamyatina A
    ACS Chem Biol; 2013 Nov; 8(11):2423-32. PubMed ID: 23952219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.
    Park SH; Kim ND; Jung JK; Lee CK; Han SB; Kim Y
    Pharmacol Ther; 2012 Mar; 133(3):291-8. PubMed ID: 22119168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two modes of ligand recognition by TLRs.
    Brodsky I; Medzhitov R
    Cell; 2007 Sep; 130(6):979-81. PubMed ID: 17889640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study.
    Qiao S; Zhang H; Sun F; Jiang Z
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting myeloid differentiation 2 for treatment of sepsis.
    Duan G; Zhu J; Xu J; Liu Y
    Front Biosci (Landmark Ed); 2014 Jun; 19(6):904-15. PubMed ID: 24896325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.
    Xing J; Li R; Li N; Zhang J; Li Y; Gong P; Gao D; Liu H; Zhang Y
    Mol Cell Biochem; 2015 Sep; 407(1-2):89-95. PubMed ID: 26037075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eritoran inhibits S100A8-mediated TLR4/MD-2 activation and tumor growth by changing the immune microenvironment.
    Deguchi A; Tomita T; Ohto U; Takemura K; Kitao A; Akashi-Takamura S; Miyake K; Maru Y
    Oncogene; 2016 Mar; 35(11):1445-56. PubMed ID: 26165843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
    Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
    J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structural basis for endotoxin-induced allosteric regulation of the Toll-like receptor 4 (TLR4) innate immune receptor.
    Paramo T; Piggot TJ; Bryant CE; Bond PJ
    J Biol Chem; 2013 Dec; 288(51):36215-25. PubMed ID: 24178299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A highly efficient hybrid peptide ameliorates intestinal inflammation and mucosal barrier damage by neutralizing lipopolysaccharides and antagonizing the lipopolysaccharide-receptor interaction.
    Wei X; Zhang L; Zhang R; Wu R; Si D; Ahmad B; Petitte JN; Mozdziak PE; Li Z; Guo H; Zhang M
    FASEB J; 2020 Dec; 34(12):16049-16072. PubMed ID: 33058296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2).
    Peluso MR; Miranda CL; Hobbs DJ; Proteau RR; Stevens JF
    Planta Med; 2010 Oct; 76(14):1536-43. PubMed ID: 20309792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-palmitoyl-D-glucosamine, a Natural Monosaccharide-Based Glycolipid, Inhibits TLR4 and Prevents LPS-Induced Inflammation and Neuropathic Pain in Mice.
    Iannotta M; Belardo C; Trotta MC; Iannotti FA; Vitale RM; Maisto R; Boccella S; Infantino R; Ricciardi F; Mirto BF; Ferraraccio F; Panarese I; Amodeo P; Tunisi L; Cristino L; D'Amico M; Di Marzo V; Luongo L; Maione S; Guida F
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of synthetic peptides that inhibit lipopolysaccharide (LPS) binding to myeloid differentiation protein-2 (MD-2).
    Yan H; Gu CG; Xu FL; Wu XH; Yin HH; Hu CX; Zhu XD; Liu F; Ge HJ; Chen LY; Zhang XY; Wang ZG; Xing Z; Li L
    J Immunother; 2013 Apr; 36(3):197-207. PubMed ID: 23502767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.